BRTX
NASDAQ · Biotechnology
Biorestorative Therapies Inc
$0.19
+0.00 (+1.75%)
Open$0.19
Previous Close$0.19
Day High$0.20
Day Low$0.18
52W High$2.05
52W Low$0.17
Volume—
Avg Volume1.12M
Market Cap4.81M
P/E Ratio—
EPS$-1.61
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+13,516.0% upside
Current
$0.19
$0.19
Target
$26.17
$26.17
$18.72
$26.17 avg
$39.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.00M | 694.7K | 1.76M |
| Net Income | -39,656,985 | -24,754,672 | 288.6K |
| Profit Margin | -3,959.4% | -3,761.4% | 16.4% |
| EBITDA | -39,812,237 | -26,232,227 | 503.0K |
| Free Cash Flow | — | — | 335.8K |
| Rev Growth | +44.2% | +44.2% | +14.5% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |